|
|
||||||||
COMMENTARY |
Jennifer Kates is with the Henry J. Kaiser Family Foundation, Washington, DC. At the time of writing, Richard Sorian was with the Institute for Health Care Research and Policy, Georgetown University, Washington, DC. Jeffrey S. Crowley is with the Institute for Health Care Research and Policy, Georgetown University, Washington, DC. Todd A. Summers is with Progressive Health Partners, Washington, DC.
Correspondence: Requests for reprints should be sent to Jennifer Kates, MPA, MA, Kaiser Family Foundation, 1450 G St, NW, Suite 250, Washington, DC 20005 (e-mail: jkates{at}kff.org).
Numerous policy challenges continue to face the United States in the third decade of the HIV/AIDS pandemic, in both the health and foreign policy arenas. They include long-standing questions about care, treatment, prevention, and research, as well as new ones introduced by the changing nature of the epidemic itself and the need to balance demands for limited resources.
These challenges concern the United States not only in its role as a world leader in combating a global epidemic, but in its decisions and focus at home, where the epidemic continues to take a toll.
This article has been cited by other articles:
![]() |
E. Seoane-Vazquez and R. Rodriguez-Monguio Negotiating antiretroviral drug prices: the experience of the Andean countries Health Policy Plan., March 1, 2007; 22(2): 63 - 72. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |